PNP Therapeutics

PNP Therapeutics^®, Inc. is a clinical-stage, biopharmaceutical company engaged in the development of a platform technology (Gedeptin^®) and proprietary products for the treatment of cancer. Learn more about PNP Therapeutics >.

On September 28, 2021, PNP entered into an Assignment and License Agreement with GeoVax, Inc., whereby GeoVax obtained an exclusive license to PNP’s intellectual property and related assets associated with Gedeptin^®.  All inquiries concerning Gedeptin^® should now be directed to GeoVax.